Samplix logo — Reveal cell function with single-cell resolution.

Samplix

Reveal cell function with single-cell resolution.

Founded 2013 Denmark Denmark 35 employees Series Unknown Total: $12.67M Biotechnology, Information Technology

General Information

Company Name Samplix
Founded Year 2013
Location Denmark Denmark +2
Employees 35
Industries Biotechnology, Information Technology
Funding Stage Series Unknown
Social

Get notified when Samplix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Samplix

Samplix is a Denmark-based biotechnology startup founded in 2013 with a focus on single-cell analysis in immunotherapy research. The company's flagship product, Xdrop, utilizes double emulsion technology to encapsulate living cells and reactive molecules in stable droplets, enabling rapid cell-cell and cell-molecule interactions during incubation. This technology allows for seamless analysis and sorting on flow cytometers, resulting in highly accurate, single-cell resolution results. The latest round of funding, a €7.50M Venture Round investment, was secured on 30 March 2023 from European Innovation Council and Fjord Capital. Samplix's innovative Xdrop and Xdrop Sort solutions cater to the needs of engineered cell therapy research, protein engineering, synthetic biology workflows, and other cell interaction- or cell secretion-based processes. The company's ability to offer a user-friendly workflow without the requirement of prior experience with fluorescence-based cell sorters positions it as a promising player in the biotechnology and information technology industries.

Taxonomy: single-cell analysis, immunotherapy research, double emulsion technology, flow cytometry, cell sorting, Xdrop technology, living cells encapsulation, reactive molecules, microenvironment, flow cytometry and sorting, engineered cell therapy research, protein engineering, synthetic biology workflows, cell interaction, cell secretion

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
30 Mar 2023
Venture Round •••••• 2
Investor
•••• ••••
30 Mar 2023
Grant •••••• 1 •••• •••• 01 Jan 2019

Samplix Alternatives & Competitors

Samplix vs

Empowering every scientist to make discoveries one cell at a time

Unknown
29 employees
Biotechnology, Health Care
Samplix vs
Kinetic River Corp.
Kinetic River Corp. United States

Custom Flow Cytometers

Grant
10 employees
Platforms
Samplix vs
Cytek Biosciences
Cytek Biosciences United States

Transcend The Conventional

448 employees
Also compare with: Samplix vs ACEA Biosciences ACEA Biosciences

FAQ About Samplix

Reveal cell function with single-cell resolution.
Samplix was founded in 2013.
Samplix is headquartered in Denmark.
Samplix operates in the following industries: Biotechnology, Information Technology.
Samplix has approximately 35 employees.
Samplix has completed 3 funding rounds, raising a total of $12.67M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Samplix include NanoCellect Biomedical, Inc., Kinetic River Corp., Cytek Biosciences, ACEA Biosciences, Sanford Stem Cell Discovery Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Samplix and NanoCellect Biomedical, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Samplix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy